-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
preface
Globally, the use of biosimilars is growing rapidly and will continue to rise over the next deca.
This article will analyze and predict the future development trend ofthe biosimilars market and the differences in usage between different regions and product type.
In recent years, the sales share of biosimilars launched in different regions and different molecules has different trend.
However, there are exceptionsat the national level , mainly due to the acceptance of doctors and patients , policy incentives, price differences , and whether the country adopts a unilateral or multi-party bidding syste.
The key driver for the development of the biosimilar market in the next decade will be the number of original products whose patents have expired during the same perio.
IQVIA Forecast Link reviews the historical use of biosimilars at the country level and provides an outlook on future use of biosimilars (by tumor, insulin and other molecules) based on historical trends and expert forecast.
At a regional level, Europe and North America are expected to remain the same in 2030, despite higher CAGRs of biosimilar usage (measured in PATDAY) in key Asian markets, Latin America and Southeast Asia, and Australasia over the next deca.
Although the use of biosimilars varies widely by molecule and region , it is certain that the market size of biosimilars will grow substantially over the next decad.
